Myeloid-Related Protein-14/MRP-14/S100A9/Calgranulin B is Associated with Inflammation in Proliferative Diabetic Retinopathy

REFERENCES

• Abu El-Asrar AM, De Hertogh G, Van den Eynde K, et al. Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT). Exp Eye Res. 2015;132:179–189.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Nawaz MI, De Hertogh G, et al. S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis. Mol Vis. 2014;20:1209–1224.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Nawaz MI, Kangave D, et al. Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy. J Diabetes Res. 2013;2013:539658.
   PubMed Web of Science ®Google Scholar
• El-Asrar AM, Nawaz MI, Kangave D, et al. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy. Mol Vis. 2011;17:1829–1838.
   Google Scholar
• Nawaz MI, Van Raemdonck K, Mohammad G, et al. Autocrine CCL2, CXCL4, CXCL9 and CXCL10 signal in retinal endothelial cells and are enhanced in diabetic retinopathy. Exp Eye Res. 2013;109:67–76.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Mohammad G, Nawaz MI, et al. Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy. PLoS One. 2013;8:e85857.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Struyf S, Van Damme J, et al. Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol. 2008;92:699–704.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Missotten L, Geboes K. Expression of myofibroblast activation molecules in proliferative vitreoretinopathy epiretinal membranes. Acta Ophthalmol. 2011;89:e115–e121.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Alam K, Nawaz MI, et al. Upregulated expression of heparanase in the vitreous of patients with proliferative diabetic retinopathy originates from activated endothelial cells and leukocytes. Invest Ophthalmol Vis Sci. 2015;56:8239–8247.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Siddique MM, Nawaz MI, et al. Co-expression of heparanase activity, cathepsin L, tissue factor, tissue factor pathway inhibitor and matrix metalloproteinase-9 in proliferative diabetic retinopathy. Mol Vis. 2016;22:424–435.
   PubMed Web of Science ®Google Scholar
• Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450–1452.
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Khosrof S, Bursell S-E, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci. 1999;96:10836–10841.
   PubMed Web of Science ®Google Scholar
• Kim YW, West XZ, Byzova TV. Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med (Berl). 2013;91:323–328.
   PubMed Web of Science ®Google Scholar
• Ono M. Molecular links between tumor angiogenesis and inflammation: inflammatory stimuli of macrophages and cancer cells as targets for therapeutic strategy. Cancer Sci. 2008;99:1501–1506.
   PubMed Web of Science ®Google Scholar
• Srikrishna G. S100A8 and S100A9: new insights into their roles in malignancy. J Innate Immun. 2012;4:31–40.
   PubMed Web of Science ®Google Scholar
• Schiopu A, Cotoi OS. S100A8 and S100A9: DAMPs at the crossroads between innate immunity, traditional risk factors, and cardiovascular disease. Mediators Inflamm. 2013;2013:828354.
   PubMed Web of Science ®Google Scholar
• Shibata F, Miyama K, Shinoda F, et al. Fibroblast growth-stimulating activity of S100A9 (MRP-14). Eur J Biochem. 2004;271:2137–2143.
   PubMedGoogle Scholar
• Anceriz N, Vandal K, Tessier PA. S100A9 mediates neutrophil adhesion to fibronectin through activation of beta2 integrins. Biochem Biophys Res Commun. 2007;354:84–89.
   PubMed Web of Science ®Google Scholar
• Ryckman C, Vandal K, Rouleau P, et al. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol. 2003;170:3233–3242.
   PubMed Web of Science ®Google Scholar
• Gebhardt C, Németh J, Angel P, et al. S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol. 2006;72:1622–1631.
   Google Scholar
• Benedyk M, Sopalla C, Nacken W, et al. HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-kappaB activities. J Invest Dermatol. 2007;127:2001–2011.
   Google Scholar
• Markowitz J, Carson WE III. Review of S100A9 biology and its role in cancer. Biochim Biophys Acta. 2013;1835:100–109.
   PubMed Web of Science ®Google Scholar
• Tong L, Lan W, Lim RR, et al. S100A proteins as molecular targets in the ocular surface inflammatory diseases. Ocul Surf. 2014;12:23–31.
   PubMed Web of Science ®Google Scholar
• Delabie J, De Wolf-Peeters C, van den Oord JJ, et al. Differential expression of the calcium-binding proteins MRP8 and MRP14 in granulomatous conditions: an Immunohistochemical study. Clin Exp Immunol. 1990;81:123–126.
   PubMed Web of Science ®Google Scholar
• Wang C, Klechikov AG, Gharibyan AL, et al. The role of pro-inflammatory S100A9 in Alzheimer’s disease amyloid-neuroinflammatory cascade. Acta Neuropathol. 2014;127:507–522.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Chang KA, Ha TY, et al. S100A9 knockout decreases the memory impairment and neuropathology in crossbreed mice of Tg2576 and S100A9 knockout mice model. PLoS One. 2014;9:e88924.
   PubMed Web of Science ®Google Scholar
• Barber A. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:283–290.
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Dralands L, Missotten L, et al. Expression of apoptosis markers in the retinas of human subjects with diabetes. Invest Ophthalmol Vis Sci. 2004;45:2760–2766.
   PubMed Web of Science ®Google Scholar
• Manitz MP, Horst B, Seeliger S, et al. Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro. Mol Cell Biol. 2003;23:1034–1043.
   PubMed Web of Science ®Google Scholar
• Croce K, Gao H, Wang Y, et al. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation. 2009;120:427–436.
   PubMed Web of Science ®Google Scholar
• Wang L, Luo H, Chen X, et al. Functional characterization of S100A8 and S100A9 in altering monolayer permeability of human umbilical endothelial cells. PLoS One. 2014;9:e90472.
   PubMed Web of Science ®Google Scholar
• Ferris FL 3rd, Patz A. Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol. 1984;28 Suppl:452–461.
   PubMed Web of Science ®Google Scholar
• Viemann D, Strey A, Janning A, et al. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood. 2005;105:2955–2962.
   PubMed Web of Science ®Google Scholar
• Viemann D, Barczyk K, Vogl T, et al. MRP8/MRP14 impairs endothelial integrity and induces a caspase-dependent and -independent cell death program. Blood. 2007;109:2453–2460.
   PubMed Web of Science ®Google Scholar
• Li C, Li S, Jia C, et al. Low concentration of S100A8/9 promotes angiogenesis-related activity of vascular endothelial cells: bridges among inflammation, angiogenesis, and tumorigenesis? Mediators Inflamm. 2012;248574.
   Google Scholar
• Chiu JJ, Lee PL, Chen CN, et al. Shear stress increases ICAM-1 and decreases VCAM-1 and E-selectin expressions induced by tumor necrosis factor-α in endothelial cells. Arterioscler Thromb Vasc Biol. 2004;24:73–79.
   PubMed Web of Science ®Google Scholar
• Tsoyi K, Kim W, Kim Y, et al. Upregulation of PTEN by CKD712, a synthetic tetrahydroisoquinoline alkaloid, selectively inhibits lipopolysaccharide-induced VCAM-1 but not ICAM-1 expression in human endothelial cells. Atherosclerosis. 2009;207:412–419.
   PubMed Web of Science ®Google Scholar
• Tsoyi K, Jang H, Nizamutdinova T, et al. PTEN differentially regulates expressions of ICAM-1 and VCAM-1 through P13K/Akt/GSK-3β/GATA-6 signaling pathways in TNF-α activated human endothelial cells. Atherosclerosis. 2010;213:115–121.
   PubMed Web of Science ®Google Scholar
• Korthagen NM, Nagtegaal MM, van Moorsel CH, et al. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases. Clin Exp Immunol. 2010;161:342–347.
   PubMed Web of Science ®Google Scholar
• Bargagli E, Olivieri C, Cintorino M, et al. Calgranulin B (S100A9/MRP14): A key molecule in idiopathic pulmonary fibrosis? Inflammation. 2011;34:85–91.
   PubMed Web of Science ®Google Scholar
• Xu X, Wu WY, Tu WZ, et al. Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities. Clin Rheumatol. 2013;32:1501–1510.
   PubMed Web of Science ®Google Scholar
• Nikitorowicz-Buniak J, Shiwen X, Denton CP, et al. Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9. J Invest Dermatol. 2014;134:2693–2702.
   PubMed Web of Science ®Google Scholar
• Xu X, Chen H, Zhu X, et al. S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways. Clin Exp Immunol. 2013;173:523–535.
   PubMed Web of Science ®Google Scholar
• El-Asrar AM, Missotten L, Geboes K. Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes. Mol Vis. 2011;17:508–518.
   PubMed Web of Science ®Google Scholar
• Mohammad G, Siddiquei MM, Othman A, et al. High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. Exp Eye Res. 2013;107:101–109.
   PubMed Web of Science ®Google Scholar